INS and metabolic syndrome: Conversely, given that the traditional metabolic markers and metabolomics data were measured concurrently, these data could reflect the pathophysiology of the progression to insulin resistance and dyslipidemia as it is recognized that reactive oxygen species and inflammation are a contributor to impairment in insulin secretion and action [44].